Press Releases

Browse MedShadow’s announcements, research launches, award news, and organizational updates.

MedShadow Poll: Americans Want Prescription Drug Advertising Reform

Half of Americans support banning prescription drug advertising, one in five view its overall effect as harmful, and two-thirds say there are too many ads According to a new national MedShadow Foundation poll conducted by…

Sep 15, 2026 Read release

MedShadow’s SSRIs Article, “Blunted Before They Can Bloom,” Wins Folio Award at Fair Media Council’s 45th Annual Folio Awards

MedShadow Foundation was recognized today at the Fair Media Council's 45th Annual Folio Awards Luncheon, held at the historic Garden City Hotel in New York.

Jun 11, 2026 Read release

MedShadow’s Investigating Generics Series Selected as a Finalist at the 18th Annual Shorty Awards

MedShadow Foundation has been shortlisted for the 18th Annual Shorty Awards for Investigating Generics in the Strategy and Engagement: On a Shoestring category, showcasing the creativity and effectiveness of its work in digital media.

Mar 30, 2026 Read release

Redesigned MedShadow.org website provides improved ways to explore side effects and safety of medications

In response to demand, MedShadow has improved design, speed, and content organization for users New York, NY - December 15, 2025 - Today, the MedShadow Foundation unveiled a sleek and modern new look and improved…

Dec 15, 2025 Read release

New Report: Americans Are Willing to Pay More for Drugs Tested for Safety, and Also Report Differences in Side Effects and Efficacy When Switching Between Manufacturers

MedShadow and Kantar's New Data Show Consumer Preferences and Experiences with Prescription Medications Two-thirds of Americans say they would pay more for drugs to be regularly tested to ensure safety and efficacy.

Jul 31, 2025 Read release

MedShadow Founder, President to Speak at PharmedOut Conference

New York, NY - May 19, 2023 - PharmedOut will host its ninth annual conference, “Making Healthy People Sick: Invented Diseases and Overdiagnosis” on June 15 and 16 at the Georgetown University Medical Center in…

May 19, 2023 Read release

What is Unbiased Drug-Safety Journalism Worth to You?

We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.

As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.